Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics

Benmessaoud, Dalila; Hamdani, Nora; Boni, Claudette; Ramoz, Nicolas; Hamon, Michel; Kacha, Farid; Gorwood, Philip
January 2008
BMC Psychiatry;2008, Vol. 8, Special section p1
Academic Journal
Background: The -1438A/G polymorphism of the 5-HT2A gene has been found to be associated with clinical response to clozapine and other second generation antipsychotics. Testing the impact of this marker on response to first generation antipsychotics (which have a lower affinity for the 5-HT2A receptor) provides the opportunity to help disentangling the two different roles that this polymorphism might have. A psychopharmacogenetic role should be detected only for antipsychotics with high affinity to the 5-HT2A receptor (therefore to second generation antipsychotics). An alternative role would imply tagging a subgroup of patients responsive to any antipsychotic, whatever their affinity, meaning that the association is more depending on non pharmacological charaterictics, such as clinical specificities. Methods: A family-based sample of 100 Algerian patients with schizophrenia (according to DSM-IV criteria) and their 200 biological parents was recruited, in order to avoid stratification biases. Patients were all treated, or have been treated, by conventional antipsychotics (mainly haloperidol) for at least four weeks, at appropriate dosage. May and Dencker scale was used to distinguish responders and non responders. Results: No allele of the -1438A/G polymorphism of the 5-HT2A gene was transmitted in excess (50 transmitted for 38 untransmitted) in the whole sample of patients with schizophrenia (p = .90). In contrast, a significant excess of transmission of the G allele was observed (p = .02) in the subgroup of patients with good treatment response (17 transmitted for 6 untransmitted). Conclusion: Using a TDT approach, we showed that the G allele of the -1438A/G polymorphism of the gene coding for the 5-HT2A receptor was associated to schizophrenia with good response to conventional antipsychotics, although this conclusion is based on 88 informative patients only. Because previous data showed the same result with atypical antipsychotics, it can be concluded that the G allele tags a subgroup of schizophrenic patients with greater chance of improvement with antipsychotics of either type.


Related Articles

  • Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population. Ran Huo; Kefu Tang; Zhiyun Wei; Lu Shen; Yuyu Xiong; Xi Wu; Jiamin Niu; Xia Han; Zhengan Tian; Lun Yang; Guoyin Feng; Lin He; Shengying Qin // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of...

  • No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies. Uchida, Naohiko; Ujike, Hiroshi; Nakata, Kenji; Takaki, Manabu; Nomura, Akira; Katsu, Takeshi; Tanaka, Yuji; Imamura, Takaki; Sakai, Ayumu; Kuroda, Shigetoshi // BMC Psychiatry;2003, Vol. 3, p13 

    Background: Several lines of evidence have supported possible roles of the sigma receptors in the etiology of schizophrenia and mechanisms of antipsychotic efficacy. An association study provided genetic evidence that the sigma receptor type 1 gene (SIGMAR1) was a possible susceptibility factor...

  • Use of Clozapine in Older Asian Patients with Schizophrenia between 2001 and 2009. Xiang, Yu-Tao; Buchanan, Robert W.; Ungvari, Gabor S.; Chiu, Helen F. K.; Lai, Kelly Y. C.; Li, You-Hong; Si, Tian-Mei; Wang, Chuan-Yue; Lee, Edwin H. M.; He, Yan-Ling; Yang, Shu-Yu; Chong, Mian-Yoon; Kua, Ee-Heok; Fujii, Senta; Sim, Kang; Yong, Michael K. H.; Trivedi, Jitendra K.; Chung, Eun-Kee; Udomratn, Pichet; Chee, Kok-Yoon // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: To date there has been no large-scale international study that examined the use of clozapine in older patients with schizophrenia. This study examined the use of clozapine and its demographic and clinical correlates in older patients with schizophrenia in East Asia during the period...

  • Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients. Nikolac Perkovic, Matea; Nedic Erjavec, Gordana; Zivkovic, Maja; Sagud, Marina; Uzun, Suzana; Mihaljevic-Peles, Alma; Kozumplik, Oliver; Muck-Seler, Dorotea; Pivac, Nela // Psychopharmacology;Sep2014, Vol. 231 Issue 18, p3757 

    Rationale: Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays a major role in neurogenesis and neuroplasticity, and in the modulation of several neurotransmitter systems including the dopaminergic system. There are mixed reports about the association between the BDNF Val66Met...

  • Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study. Shing, Emily C.; Tiwari, arun K.; Brandl, Eva J.; Zai, Clement C.; Lieberman, Jeffrey a.; Meltzer, Herbert Y.; Kennedy, James L.; Müller, Daniel J. // Neuropsychobiology;Feb2014, Vol. 69 Issue 1, p59 

    Objectives: Genetic variation in the fat mass- and obesity-associated gene (FTO) has been associated with obesity in the general population. In this study we have investigated these variants for association with antipsychotic-induced weight gain (AIWG). Methods: A total of 218 patients with...

  • The Influence of Clozapine and Typical Neuroleptics on Information Processing ofthe Central Nervous System under Clinical Conditions in Schizophrenic Disorders: Implications for Fitness to Drive. Grabe; Wolf; Grätz; Laux // Neuropsychobiology;1999, Vol. 40 Issue 4, p196 

    The present study investigates the psychomotor performance of schizophrenic inpatients receiving neuroleptic medication and comedication according to their clinical demands in regard to their fitness to drive. The hypothesis was tested that even under polydrug medication, the clozapine-treated...

  • Association of autonomic dysfunction and clozapine. Cohen, Hagit; Loewenthal, Uri; Matar, Michael; Kotler, Moshe // British Journal of Psychiatry;Aug2001, Vol. 179, p167 

    Background Antipsychotic medications cause a wide range of adverse effects and have been associated with sudden death in psychiatric patients. Aims To supply power spectral analysis of heart rate variability as a tool to examine the arrythmogenic effects of neuroleptics. Method Heart rate...

  • Impact of the AHI1 Gene on the Vulnerability to Schizophrenia: A Case-Control Association Study. Rivero, Olga; Reif, Andreas; Sanjuán, Julio; Moltó, María D.; Kittel-Schneider, Sarah; Nájera, Carmen; Töpner, Theresia; Lesch, Klaus-Peter // PLoS ONE;2010, Vol. 5 Issue 8, p1 

    Background: The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys)function, a linkage scan in large pedigrees identified AHI1 as a positional...

  • Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics. Liou, Y-J; Bai, Y M; Lin, E; Chen, J-Y; Chen, T-T; Hong, C-J; Tsai, S-J // Pharmacogenomics Journal;Feb2012, Vol. 12 Issue 1, p54 

    The use of atypical antipsychotics (AAPs) is associated with increasing the risk of the metabolic syndrome (MetS), which is an important risk factor for cardiovascular disease and diabetes. Two insulin-induced gene (INSIG) isoforms, designated INSIG-1 and INSIG-2 encode two proteins that mediate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics